Boehringer Ingelheim To Focus On Precision Psychiatry In CNS

R&D Mission: Explore Brain’s Biological Circuitry

 
• By Sten Stovall

Boehringer Ingelheim will increasingly use external collaborations in its search for new treatment options for neuropsychiatric diseases, its CNS R&D head tells Scrip.

Brain Circuitry
Boehringer Ingelheim is pursing CNS innovation via collaborations, too. • Source: Shutterstock

More from Business

More from Scrip